Search

Your search keyword '"Stingl H"' showing total 91 results

Search Constraints

Start Over You searched for: Author "Stingl H" Remove constraint Author: "Stingl H"
91 results on '"Stingl H"'

Search Results

2. Euglycemic Diabetic Ketoacidosis in COVID-19 Patient Caused by Empagliflozin: A Case Report from Intensive Care Unit

5. Measurement of fractional whole-body gluconeogenesis in humans from blood samples using ²H nuclear magnetic resonance spectroscopy

9. Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes

20. Effects of short-term improvement of insulin treatment and glycemia on hepatic glycogen metabolism in type 1 diabetes.

21. 35th Annual Meeting of the European Association for the Study of Diabetes

22. 35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999

26. Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care - The countrywide cross-sectional AUSTRO-PROFIT study.

27. [Position paper: Open-source technology in the treatment of people living with diabetes mellitus-an Austrian perspective : Technology Committee of the Austrian Diabetes Association].

28. [Diabetes mellitus, coronary artery disease and heart disease (Update 2023)].

29. [Lipids-Diagnosis and therapy in diabetes mellitus (Update 2023)].

30. [Diabetic kidney disease (update 2023) : Position paper of the Austrian Diabetes Association and the Austrian Society for Nephrology].

31. [Geriatric aspects for the management of diabetes mellitus (Update 2023)].

32. [Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)].

33. Biomarkers Predictive for In-Hospital Mortality in Patients with Diabetes Mellitus and Prediabetes Hospitalized for COVID-19 in Austria: An Analysis of COVID-19 in Diabetes Registry.

34. COVID-19 In-Hospital Mortality in People with Diabetes Is Driven by Comorbidities and Age-Propensity Score-Matched Analysis of Austrian National Public Health Institute Data.

36. Covid-19: Involvement of the nervous system. Identifying neurological predictors defining the course of the disease.

37. Assessing the health-related quality of life in type 2 diabetes patients treated with insulin and oral antidiabetic agents.

38. EVL regulates VEGF receptor-2 internalization and signaling in developmental angiogenesis.

39. COVID-19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission.

40. Assessing the quality of life among patients with diabetes in Austria and the correlation between glycemic control and the quality of life.

41. AKAP12 deficiency impairs VEGF-induced endothelial cell migration and sprouting.

42. Nitric oxide maintains endothelial redox homeostasis through PKM2 inhibition.

43. [Geriatric aspects for the management of diabetes mellitus (Update 2019)].

44. [Diabetes mellitus, coronary artery disease und heart disease (Update 2019)].

45. [Insulin therapy of type 2 diabetes mellitus (Update 2019)].

46. [Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)].

47. [Lipids-Diagnosis and therapy in diabetes mellitus (Update 2019)].

48. Risk factors for decline in renal function among young adults with type 1 diabetes.

49. Endothelial AMP-Activated Kinase α1 Phosphorylates eNOS on Thr495 and Decreases Endothelial NO Formation.

50. Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss.

Catalog

Books, media, physical & digital resources